The connection between the differential anti-cancer efficacies of EZH2 inhibitor in PTEN-positive versus PTEN-negative cancer cells with FOXO1 protein induction and cellular localization further highlights the essential role of FOXO1 in EZH2 inhibitor-induced death of cancer cells. Here, FOXO1 is linked to cancer.